Get started
CASSAVA SCIENCES INCCASSAVA SCIENCES INCCASSAVA SCIENCES INC

CASSAVA SCIENCES INC

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals

SAVA trade ideas

SAVA, Aroon Indicator entered an Uptrend on February 02, 2021.Over the last three days, Tickeron's A.I.dvisor has detected that SAVA's AroonUp green line (see chart) is above 70, while the AroonDown red line is below 30. When the green line goes above 70 while the red line stays below 30, this is an indicator that the stock could be poised for a strong Uptrend. For traders, this could mean going long the stock or exploring call options in the next month. Tickeron's A.I.dvisor backtested this indicator and found 185 similar cases, 161 of which were successful. Based on this data, the odds of success are 87%. Current price $77.19 is above $12.32 the highest resistance line found by Tickeron A.I. Throughout the month of 12/30/20 - 02/02/21, the price experienced a +691% Uptrend. During the week of 01/26/21 - 02/02/21, the stock enjoyed a +185% Uptrend growth. Bullish Trend Analysis The Momentum Indicator moved above the 0 level on January 06, 2021. You may want to consider a long position or call options on SAVA as a result. In 73 of 90 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 81%. The Moving Average Convergence Divergence (MACD) for SAVA just turned positive on January 05, 2021. Looking at past instances where SAVA's MACD turned positive, the stock continued to rise, Tickeron A.I. shows that in 31 of 38 cases over the following month. The odds of a continued upward trend are 82%. SAVA moved above its 50-day Moving Average on January 13, 2021 date and that indicates a change from a downward trend to an upward trend. The 10-day Moving Average for SAVA crossed bullishly above the 50-day moving average on January 14, 2021. This indicates that the trend has shifted higher and could be considered a buy signal. Tickeron A.I. detected that in 13 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 87%. Following a +179.72% 3-day Advance, the price is estimated to grow further. Considering data from situations where SAVA advanced for three days, in 206 of 233 cases, the price rose further within the following month. The odds of a continued upward trend are 88%. The Aroon Indicator entered an Uptrend today. Tickeron A.I. detected that in 161 of 185 cases where SAVA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 87%.
NASDAQ:SAVALong
by AlTorress
1
Simufilam Improves Cognition and Behavior in Alzheimer’s DiseaseCassava Sciences’ Simufilam Improves Cognition and Behavior in Alzheimer’s Disease in Interim Analysis of Open-label Study - Patients’ Cognition Improved 1.6 Points on ADAS-Cog11 -a 10% mean improvement from baseline to month 6. - Patients’ Behavior Improved 1.3 Points on NPI, a 29% mean improvement from baseline to month 6. - Improvements Maintained at 6 Months - - Results Support Advancing Simufilam into Phase 3 Clinical Program Next Steps: Cassava Sciences believes today’s data and prior clinical results support advancing simufilam into a Phase 3 clinical program in Alzheimer’s disease. Initiation of a Phase 3 trial remains on schedule for 2nd half 2021. Cassava Sciences and the U.S. FDA recently concluded a successful end-of-phase 2 (EOP2) meeting for the simufilam drug development program. Details of the EOP2 meeting will be announced Q1 2021 after official FDA meeting minutes are finalized. finance.yahoo.com
NASDAQ:SAVA
by AlenCiken
Cassava Sciences SAVA pullback, then parabolic againBullish for near term on Cassava Sciences. What can I say, SAVA went through the roof the past 2 weeks. News on big insider purchases by it's chief financial officer & chief executive officer and positive data on it's Alzheimer's drug has nearly quadrupled it's share price in 10 trading days. From a share price of $3.32 close on Friday 9/11, to a high of $12.34 this Friday 9/25 (272%). SAVA was above it's 9 moving average the past 2 days, so look for a pullback and some profit taking on Monday 9/28. It seems to have a pattern of no more than 2 days in a row above it's 9MA. A fair entry next week would be between $9.69 - 9.89. After that level, it's back & off to the races going parabolic for 2 days and then rest again for around 3 days. A reasonably near term exit for this trade would be to sell at $14.25 during a parabolic move or simply get a $12.5 Put to put a floor under it during the spike to get it on discount, not after the fact. lol. Because SAVA has spiked up so quickly, it wouldn't be a bad idea to get a cheap $7.5 protective Put just in case in the meantime. As for playing SAVA options, you could get a 2:1 ratio bullish strangle, making sure to purchase the Put & calls in a separate order, so you can sell (direct value) them or add to (inverse direction discount) them in relation to it's daily momentum. We all know it's impossible to predict the peak share price at any given time frame, but I would not be surprised if SAVA peaks at +$20 by 10/16. Good luck and happy trading friends.
NASDAQ:SAVA
by Options360
2